Answers are grounded in this paper and cite their sources.
Prospective observational study assesses functional outcomes post partial glossectomy in tongue carcinoma patients, indicating reconstruction type impacts quality of life.
237 Background: Tongue resection for carcinoma significantly impacts essential functions such as speech, swallowing, and tongue mobility. While various reconstruction techniques are available, their comparative impact on long-term function remains inadequately studied, especially within a standardized surgical framework. Methods: This prospective study included 42 patients with T1–T3 squamous cell carcinoma of the tongue who underwent Type II glossectomy at a tertiary cancer center. Patients were stratified into three reconstruction groups: primary closure, MatriDerm-assisted secondary intention healing, and flap reconstruction. Functional outcomes were assessed at 6–12 months postoperatively using validated instruments: EAT-10 for swallowing, Speech Handicap Index (SHI) for speech, Tongue Motility Assessment (TMA), and EORTC QLQ-F17 and HN35 for quality of life. Results: Swallowing outcomes were largely preserved, with a mean EAT-10 score of 3.05. MatriDerm group had the lowest swallowing difficulty, though differences between groups were not statistically significant (p = 0.079). SHI and TMA scores showed significant variation (p = 0.013 and p < 0.001, respectively), with flap reconstructions associated with worse outcomes. RAFF flaps performed better than bulkier options like ALT. Radiotherapy and chemotherapy were significantly associated with poorer function and QoL (p < 0.05). QoL scores were generally good, but subjective perceptions were lower in older patients. Tumor size, stage, and reconstruction type significantly influenced outcomes. Conclusions: MatriDerm and primary closure offered superior functional outcomes in partial glossectomy compared to flap reconstruction, particularly in T1–T2 tumors. The use of a standardized glossectomy classification (Ansarin et al.) enhanced methodological clarity. Future studies should explore long-term outcomes across broader populations and incorporate routine rehabilitative strategies. Clinical trial information: CTRI/2024/03/063482 . Demography of the patient. Clinical Details Mean ± SD || Median (IQR) || Min-Max OR N (%) Age (Years) 56.33 ± 12.00 || 57.50 (48.25-66.50) || 30.00 - 78.00 Surgery Type PG+ND + Flap Reconstruction 18 (42.9%) PG+ND + Primary Closure 16 (38.1%) PG+ND + Matriderm Placement 8 (19.0%) Neck Dissection Type SOHND 25 (59.5%) MND 11 (26.2%) Ext-SOHND 6 (14.3%) Flap Type Used RAFF Flap 5 (27.8%) ALT Flap 4 (22.2%) Infrahyoid Flap 4 (22.2%) Nasolabial Flap 2 (11.1%) FAMM Flap 1 (5.6%) MSAP flap 1 (5.6%) Submental Flap 1 (5.6%) Post-Operative Hospital Stay (Days) 6.02 ± 2.90 || 5.00 (4.00-7.00) || 3.00 - 13.00 pT Stage T1 5 (11.9%) T2 19 (45.2%) T3 18 (42.9%) pN Stage N0 19 (45.2%) N1
No takes yet. Share an insight, caveat, or question.
Anand et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: